External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort.

MLA

Hagens, Marinus J., et al. “External Validation of the Rotterdam Prostate Cancer Risk Calculator within a High-Risk Dutch Clinical Cohort.” World Journal of Urology, vol. 41, no. 1, Jan. 2023, pp. 13–18. EBSCOhost, https://doi.org/10.1007/s00345-022-04185-y.

APA

Hagens, M. J., Stelwagen, P. J., Veerman, H., Rynja, S. P., Smeenge, M., van der Noort, V., Roeleveld, T. A., van Kesteren, J., Remmers, S., Roobol, M. J., van Leeuwen, P. J., & van der Poel, H. G. (2023). External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort. World Journal of Urology, 41(1), 13–18. https://doi.org/10.1007/s00345-022-04185-y

Chicago

Hagens, Marinus J., Piter J. Stelwagen, Hans Veerman, Sybren P. Rynja, Martijn Smeenge, Vincent van der Noort, Ton A. Roeleveld, et al. 2023. “External Validation of the Rotterdam Prostate Cancer Risk Calculator within a High-Risk Dutch Clinical Cohort.” World Journal of Urology 41 (1): 13–18. doi:10.1007/s00345-022-04185-y.